尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the detailed record of transactions filed by Squinto Stephen P, 董事. Officer active across 2 companies, notably SpringWorks Therapeutics, Inc.. Cumulatively, 2 disclosures have been logged. Activity tracked since 20 May 2021. The latest transaction was filed on 19 May 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Stephen P. Squinto is a Board Member at SpringWorks Therapeutics, Inc. He brings significant expertise in the biopharmaceutical field, contributing to the strategic direction of the company. His prior experience in drug development enables him to assess projects and research initiatives. As a board member, Stephen P. Squinto plays a crucial role in overseeing operations and aligning the company's goals with patient needs.